Bente Vinda

3rd June 2019
Watrium underwrites listing of Ultimovacs

Ultimovacs is a pharmaceutical company developing novel immunotherapies against cancer. The lead product candidate is UV1, a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen...

Continue Reading
9th May 2019
Watrium supports listing of DF Capital

Watrium supports the listing of DF Capital on AIM as cornerstone investor.

Continue Reading
Front deck on a boat
28th February 2019
Flexiteek International to acquire Wilks

Watrium’s portfolio company Flexiteek International, the global leader in synthetic teak decking and the 2G technology, has reached an agreement to acquire Wilks, manufacturer, and supplier of Dek-King synthetic teak...

Continue Reading